X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-29 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $21.78 | -408 | 158,171 | 0% | -$8,886 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $21.78 | -345 | 64,683 | -1% | -$7,514 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $21.78 | -517 | 318,483 | 0% | -$11,260 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $21.78 | -574 | 125,969 | 0% | -$12,502 | ||||||
2024-05-29 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $21.78 | -345 | 118,894 | 0% | -$7,514 | ||||||
| D | 2024-05-29 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $141.40 | -20,000 | 21,299 | -48% | -$2,828,025 | |||||
2024-05-29 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale | $141.65 | -1,193 | 10,732 | -10% | -$168,988 | ||||||
| M | 2024-05-28 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.90 | +9,026 | 2,774,719 | 0% | +$17,186 | |||||
| D | 2024-05-24 | ITGR | Integer Holdings Corp | Hinrichs James F. | Dir | S - Sale+OE | $122.44 | -9,603 | 7,424 | -56% | -$1,175,772 | |||||
2024-05-17 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.18 | -73 | 119,239 | 0% | -$1,619 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.18 | -98 | 319,000 | 0% | -$2,174 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.18 | -115 | 126,543 | 0% | -$2,551 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $22.18 | -85 | 158,579 | 0% | -$1,885 | ||||||
2024-05-17 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.18 | -57 | 65,028 | 0% | -$1,264 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $3.53 | -3,918 | 318,959 | -1% | -$13,831 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $3.53 | -1,097 | 241,413 | 0% | -$3,872 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $3.53 | -2,972 | 243,875 | -1% | -$10,491 | ||||||
2024-05-16 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.53 | -5,237 | 924,574 | -1% | -$18,487 | ||||||
2024-05-15 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.67 | -10,000 | 119,312 | -8% | -$226,700 | ||||||
| D | 2024-05-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $135.32 | -8,625 | 531,002 | -2% | -$1,167,147 | |||||
2024-05-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $0.88 | -2,753 | 93,773 | -3% | -$2,423 | ||||||
| M | 2024-05-14 | CUTR | Cutera Inc | Karavitis Michael | EVP, CTO | S - Sale | $2.60 | -63,603 | 0 | -100% | -$165,438 | |||||
2024-05-10 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale | $129.82 | -2,500 | 11,193 | -18% | -$324,550 | ||||||
| A | 2024-05-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale | $108.54 | -63,260 | 20,843 | -75% | -$6,866,104 | |||||
2024-05-10 | ITGR | Integer Holdings Corp | Khales Payman | Pres, C, V | S - Sale | $113.84 | -8,712 | 10,431 | -46% | -$991,739 | ||||||
2024-05-13 | CNMD | Conmed Corp | Bronson David M | Dir | P - Purchase | $72.09 | +1,350 | 16,460 | +9% | +$97,322 | ||||||
| M | 2024-05-10 | SDPI | Superior Drilling Products, Inc. | Eberwein Jeffrey E. | 10% | S - Sale | $1.24 | -40,000 | 3,024,012 | -1% | -$49,646 | |||||
2024-05-10 | OM | Outset Medical, Inc. | Racine Jean-Olivier | CTO | S - Sale | $3.27 | -8,306 | 265,325 | -3% | -$27,161 | ||||||
2024-05-08 | CNMD | Conmed Corp | Schwarzentraub Barbara J | Dir | P - Purchase | $69.26 | +1,442 | 5,005 | +40% | +$99,873 | ||||||
2024-05-07 | ITGR | Integer Holdings Corp | Harris John A | EVP, Global Ops, Manufactur | S - Sale | $113.00 | -312 | 1,157 | -21% | -$35,256 | ||||||
2024-05-07 | ITGR | Integer Holdings Corp | Senn Andrew | SVP, Strategy, Business Dev | S - Sale | $113.14 | -5,000 | 4,658 | -52% | -$565,708 | ||||||
| M | 2024-05-06 | SVVC | Firsthand Technology Value Fund, Inc. | Star Equity Fund, LP | 10% | P - Purchase | $0.22 | +44,105 | 2,029,829 | +2% | +$9,683 | |||||
2024-05-06 | TMDX | Transmedics Group, Inc. | Corcoran Nicholas | See Remarks | S - Sale | $129.91 | -3,222 | 21,105 | -13% | -$418,570 | ||||||
| D | 2024-05-06 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $128.00 | -15,000 | 23,299 | -39% | -$1,920,000 | |||||
2024-05-07 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale | $129.98 | -7,157 | 1,193 | -86% | -$930,278 | ||||||
| D | 2024-05-06 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $130.07 | -5,839 | 20,843 | -22% | -$759,479 | |||||
| D | 2024-05-06 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $130.07 | -30,000 | 531,002 | -5% | -$3,902,100 | |||||
2024-05-06 | CNMD | Conmed Corp | Aronson Martha Goldberg | Dir | P - Purchase | $70.98 | +2,000 | 13,610 | +17% | +$141,960 | ||||||
2024-05-03 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $125.05 | -12,025 | 194,339 | -6% | -$1,503,687 | ||||||
2024-05-01 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $106.43 | -15,040 | 206,364 | -7% | -$1,600,633 | ||||||
| DM | 2024-05-01 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $116.68 | -68,444 | 531,002 | -11% | -$7,986,219 | |||||
| D | 2024-05-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $109.78 | -78,036 | 20,843 | -79% | -$8,566,837 | |||||
2024-04-30 | ITGR | Integer Holdings Corp | Thomas Tommy P | VP, Corporate Controller | S - Sale | $114.00 | -1,500 | 2,813 | -35% | -$171,000 | ||||||
2024-04-30 | CNMD | Conmed Corp | Beyer Pat | COO | P - Purchase | $68.30 | +3,000 | 10,807 | +38% | +$204,900 | ||||||
| M | 2024-04-29 | SLNO | Soleno Therapeutics Inc | Vivo Opportunity, LLC | 10% | S - Sale | $46.95 | -1,101,242 | 7,316,851 | -13% | -$51,701,551 | |||||
| D | 2024-04-26 | MASI | Masimo Corp | Reynolds Craig B | Dir | S - Sale+OE | $136.17 | -40,000 | 7,406 | -84% | -$5,446,616 | |||||
| M | 2024-04-18 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $15.95 | -758 | 65,085 | -1% | -$12,093 | |||||
2024-04-18 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $15.31 | -481 | 158,664 | 0% | -$7,364 | ||||||
2024-04-18 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $15.31 | -584 | 319,098 | 0% | -$8,941 | ||||||
2024-04-18 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $15.31 | -332 | 129,312 | 0% | -$5,083 | ||||||
2024-04-18 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $15.31 | -956 | 126,658 | -1% | -$14,636 | ||||||
| D | 2024-04-17 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.12 | -4,000 | 543,446 | -1% | -$380,480 | |||||
2024-04-15 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $15.67 | -10,000 | 129,644 | -7% | -$156,700 | ||||||
| D | 2024-04-02 | MOVE | Movano Inc. | Caballero Ruben | Dir | P - Purchase | $0.00 | +22,000 | 80,200 | +38% | +$0 | |||||
| D | 2024-04-10 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.09 | -12,000 | 543,446 | -2% | -$1,141,080 | |||||
| DM | 2024-04-08 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.35 | -19,900 | 51,012 | -28% | -$1,798,002 | |||||
2024-04-08 | MDT | Medtronic Plc | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale | $83.14 | -854 | 27,925 | -3% | -$71,002 | ||||||
| DM | 2024-04-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $80.21 | -10,000 | 51,012 | -16% | -$802,084 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cogan Jeremy | CFO | P - Purchase | $0.00 | +45,000 | 780,649 | +6% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cullinan Brian | Dir | P - Purchase | $0.00 | +44,000 | 260,070 | +20% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Fairbairn Emily | Dir | P - Purchase | $0.00 | +4,690,000 | 5,916,999 | +382% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Mastrototaro John | CEO | P - Purchase | $0.00 | +176,500 | 291,642 | +153% | +$0 | |||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $41.34 | -2,218 | 23,422 | -9% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $41.34 | -5,175 | 62,953 | -8% | -$213,937 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $41.34 | -2,218 | 50,924 | -4% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $41.34 | -18,980 | 152,790 | -11% | -$784,645 | ||||||
2024-04-01 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.65 | -4,000 | 65,843 | -6% | -$70,600 | ||||||
| D | 2024-04-01 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $74.01 | -15,000 | 23,299 | -39% | -$1,110,150 | |||||
2024-03-27 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.99 | -454 | 319,682 | 0% | -$8,167 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $17.99 | -515 | 139,644 | 0% | -$9,265 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $17.99 | -395 | 159,145 | 0% | -$7,106 | ||||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Zaderej Karen L. | CEO | S - Sale+OE | $7.68 | -39,280 | 1,143,788 | -3% | -$301,670 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | S - Sale+OE | $7.68 | -4,578 | 177,474 | -3% | -$35,159 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Scopelianos Angelo | Chief R, D Officer | S - Sale+OE | $7.68 | -6,881 | 57,994 | -11% | -$52,846 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Donovan Michael Patrick | VP Operations | S - Sale+OE | $7.68 | -6,033 | 54,250 | -10% | -$46,333 | |||||
2024-03-21 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $17.83 | -520 | 127,614 | 0% | -$9,272 | ||||||
2024-03-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $2.13 | -2,391 | 242,510 | -1% | -$5,093 | ||||||
| M | 2024-03-12 | BLFS | Biolife Solutions Inc | Duross Amy | Dir | S - Sale | $16.92 | -11,200 | 29,443 | -28% | -$189,541 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $16.64 | -7,508 | 140,159 | -5% | -$124,962 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.64 | -6,834 | 320,136 | -2% | -$113,701 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | S - Sale | $16.64 | -3,804 | 65,998 | -5% | -$63,315 | |||||
2024-03-12 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $16.60 | -7,249 | 461,854 | -2% | -$120,333 | ||||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $16.64 | -7,610 | 128,134 | -6% | -$126,622 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $16.65 | -5,496 | 159,540 | -3% | -$91,495 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $16.65 | -4,630 | 69,843 | -6% | -$77,079 | |||||
| D | 2024-03-08 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $87.80 | -1,417 | 51,012 | -3% | -$124,413 | |||||
2024-03-08 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale | $87.63 | -1,903 | 23,299 | -8% | -$166,760 | ||||||
2024-03-07 | AXGN | Axogen, Inc. | Donovan Michael Patrick | VP Operations | S - Sale | $8.81 | -36,310 | 35,708 | -50% | -$319,891 | ||||||
2024-03-07 | AXGN | Axogen, Inc. | Freitag Gregory Gene | Dir | S - Sale | $9.00 | -25,000 | 271,594 | -8% | -$225,000 | ||||||
| D | 2024-03-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $82.99 | -10,000 | 52,329 | -16% | -$829,892 | |||||
| D | 2024-03-04 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $82.80 | -15,000 | 25,202 | -37% | -$1,242,000 | |||||
2024-03-01 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $83.63 | -13,380 | 221,404 | -6% | -$1,118,955 | ||||||
2024-03-01 | ELMD | Electromed, Inc. | Cunniff James L. | CEO, Pres | P - Purchase | $15.25 | +9,000 | 10,000 | +900% | +$137,250 | ||||||
2024-03-01 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $3.15 | -1,584 | 322,877 | 0% | -$4,990 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.35 | -58 | 41,806 | 0% | -$1,006 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $17.35 | -97 | 64,823 | 0% | -$1,683 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | S - Sale | $17.35 | -131 | 58,120 | 0% | -$2,273 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $17.35 | -111 | 115,688 | 0% | -$1,926 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.35 | -101 | 275,214 | 0% | -$1,752 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $17.35 | -87 | 123,940 | 0% | -$1,509 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |